Frontlight ResearchEarly access
Irritable bowel syndrome trials in Singapore
1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Single-arm, Open-label Clinical Trial to Evaluate the Effect of SMT04 in Irritable Bowel Syndrome (IBS)
- Where
- Singapore
- Age
- 21 years to 55 years
- People
- 40
- Run by
- Changi General Hospital
See details and how to joinNCT06636513